Long-QT syndrome: from genetics to management.
Department of Molecular Medicine, University of Pavia, Pavia, Italy. peter.schwartz@unipv.it
Peter J
PJ
Schwartz
Lia
L
Crotti
Roberto
R
Insolia
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000818:Animals; D004252:DNA Mutational Analysis; D017147:Defibrillators, Implantable; D004554:Electric Countershock / Q000295:instrumentation; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing / Q000379:methods; D015316:Genetic Therapy; D006801:Humans; D008133:Long QT Syndrome / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics* / Q000628:therapy*; D009154:Mutation; D010641:Phenotype; D015995:Prevalence; D013562:Sympathectomy
D000319:Adrenergic beta-Antagonists